Status:
COMPLETED
Functional Connectome in Prader-Willi Syndrome: Neuroimaging and AI to Assess Therapeutic Impact
Lead Sponsor:
Corporacion Parc Tauli
Conditions:
Prader Willi Syndrome
Hyperphagia
Eligibility:
All Genders
18+ years
Brief Summary
The goal of this observational study is to explore brain network changes and identify patterns related to hyperphagia, hormonal treatment effects, and cognitive deficits in adults with Prader-Willi Sy...
Detailed Description
Prader-Willi Syndrome (PWS) is a rare genetic condition marked by issues like constant hunger, obesity, hormonal imbalances, and cognitive difficulties. While studies have shown changes in brain conne...
Eligibility Criteria
Inclusion
- Genetically confirmed diagnosis of Prader-Willi Syndrome.
- Age older than 18 years old.
Exclusion
- Age younger than 18 years old.
- Contraindications for fMRI.
- Visual defects.
Key Trial Info
Start Date :
March 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 15 2025
Estimated Enrollment :
101 Patients enrolled
Trial Details
Trial ID
NCT06900335
Start Date
March 1 2025
End Date
March 15 2025
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Consorci Corporació Sanitària Parc Taulí
Sabadell, Barcelona, Spain, 08202